Table 3.
Linear B-cell epitopes in the final MEV vaccine construct.
| B-Cell Epitope | Position | Antigenicity |
|---|---|---|
| LTQNPQLGISFAAY | 67 | 1.15 |
| SSEGNISPSQVYAA | 126 | 0.67 |
| IGKCSTRGRKCCRR | 30 | 1.27 |
| LPKEEQIGKCSTRG | 24 | 0.75 |
| RQNKPPNKAAYCSI | 85 | 0.76 |
| STPVTLSKDQLGPG | 232 | 0.70 |
| LAETCKAAYFFPLA | 177 | 0.57 |
| SPLAAYSVSFFPLA | 165 | 0.82 |
| NNPTCWAICKAAYS | 113 | 0.59 |
| YAAYETVIEFQQKN | 137 | 1.19 |
| LSKAAYRSTPVTLS | 225 | 1.10 |
| AAYCSICSNNPTCW | 93 | 0.57 |
| YSLYVKGEPIINFA | 200 | 0.73 |
| SFAAYTTKQRQNKP | 76 | 0.85 |
| FAAYCKARSTPVTL | 212 | 1.22 |
| AAYCSNNPTCWAIC | 108 | 0.82 |
| QKNNRAAYDTPCWK | 148 | 0.77 |
| VSFFPLAETCKAAY | 172 | 0.60 |
| GEPIINFAAYCKAR | 206 | 0.56 |
| AYDTPCWKLHTSPL | 154 | 0.64 |
| CKAAYSSEGNISPS | 121 | 0.77 |